0001179110-15-011396.txt : 20150721
0001179110-15-011396.hdr.sgml : 20150721
20150721183530
ACCESSION NUMBER: 0001179110-15-011396
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150720
FILED AS OF DATE: 20150721
DATE AS OF CHANGE: 20150721
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: von Emster Kurt
CENTRAL INDEX KEY: 0001588856
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 15998681
MAIL ADDRESS:
STREET 1: C/O CYMABAY THERAPEUTICS, INC.
STREET 2: 3876 BAY CENTER PLACE
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
edgar.xml
FORM 4 -
X0306
4
2015-07-20
0
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001588856
von Emster Kurt
C/O CYMABAY THERAPEUTICS, INC.
7999 GATEWAY BLVD, SUITE 130
NEWARK
CA
94560
1
0
0
0
Common Stock
2015-07-20
4
P
0
1600000
2.81
A
1600000
I
See footnote
Common Stock
17326
I
By The Konrad Hans von Emster III and Elizabeth F. von Emster Revocable Trust dated January 18, 2005
Consists of (i) 533,333 shares held by Abingworth Bioventures VI, LP ("ABV VI"), and (ii) 1,066,667 shares held by Abingworth Bioequities Master Fund Limited ("ABE," and collectively with ABV VI, the "Abingworth Funds").
Abingworth LLP ("ALLP") provides advisory services to the Abingworth Funds. Kurt von Emster ("Emster") is a member of ALLP. Emster may be deemed the indirect beneficial owner of the shares through his indirect interest in the Abingworth Funds. Emster disclaims beneficial ownership of the shares except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that ALLP, the Abingworth Funds, Emster or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
/s/ Sujal Shah, by power of attorney
2015-07-21